Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fertility preservation

Fertility preservation editorial memo (2020) 13:361–362 https://doi.org/10.1007/s12254-020-00654-5 Bettina Böttcher · Julian Marschalek Received: 13 September 2020 / Accepted: 16 September 2020 © Springer-Verlag GmbH Austria, part of Springer Nature 2020 Research into fertility preservation (FP) techniques the problem that physicians are unfamiliar with the has increasingly gained in importance over the last options of FP. few years, as improved oncologic screening methods Applied FP techniques range from established to and therapies progressively result in cancer being experimental surgical procedures, from suppression diagnosed at a younger age, thus, ensuring better of the hypothalamic–ovarian axis to controlled ovar- survival rates following oncologic therapy. ian hyperstimulation—in order to gather mature It is well known, however, that chemo- and radio- oocytes and perform an oocyte or embryo cryop- therapy bear the risk of irreversible impairment of reservation. Which FP technique to choose or which a woman’s fertility to the extent of premature ovar- to combine is a crucial step in counseling patients. ian insufficiency (POI). Furthermore, more and more Particularly, the anticipated risk of impaired fertility non-oncologic conditions are steadily securing access has to be taken into account with reference to the to FP techniques. This is a consequence of an in- risks, benefits and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Fertility preservation

Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/fertility-preservation-TFZwSl14G1

References (7)

Publisher
Springer Journals
Copyright
2020 Springer-Verlag GmbH Austria, part of Springer Nature
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-020-00654-5
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2020) 13:361–362 https://doi.org/10.1007/s12254-020-00654-5 Bettina Böttcher · Julian Marschalek Received: 13 September 2020 / Accepted: 16 September 2020 © Springer-Verlag GmbH Austria, part of Springer Nature 2020 Research into fertility preservation (FP) techniques the problem that physicians are unfamiliar with the has increasingly gained in importance over the last options of FP. few years, as improved oncologic screening methods Applied FP techniques range from established to and therapies progressively result in cancer being experimental surgical procedures, from suppression diagnosed at a younger age, thus, ensuring better of the hypothalamic–ovarian axis to controlled ovar- survival rates following oncologic therapy. ian hyperstimulation—in order to gather mature It is well known, however, that chemo- and radio- oocytes and perform an oocyte or embryo cryop- therapy bear the risk of irreversible impairment of reservation. Which FP technique to choose or which a woman’s fertility to the extent of premature ovar- to combine is a crucial step in counseling patients. ian insufficiency (POI). Furthermore, more and more Particularly, the anticipated risk of impaired fertility non-oncologic conditions are steadily securing access has to be taken into account with reference to the to FP techniques. This is a consequence of an in- risks, benefits and

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Dec 1, 2020

Keywords: oncology; medicine/public health, general

There are no references for this article.